Management of patients with obstructive sleep apnea

Journal of Family Practice

Volumn 57, Issue 8 SUPPL., 2008, Pages

  Ballard, Robert D ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARMODAFINIL; FLUOXETINE; MIRTAZAPINE; MODAFINIL; OXYBATE SODIUM; PAROXETINE; PROTRIPTYLINE; RESPIRATORY STIMULANT AGENT;

CLINICAL TRIAL; CONSERVATIVE TREATMENT; CRANIOFACIAL SURGERY; DEVICE; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; LASER SURGERY; OXYGEN THERAPY; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PROSTHESIS; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; SLEEP APNEA SYNDROME; SOMNOLENCE; TREATMENT OUTCOME; UVULOPALATOPHARYNGOPLASTY; WEIGHT GAIN;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FATIGUE; HUMANS; SEROTONIN UPTAKE INHIBITORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 49449083289     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Mador MJ, Kufel TJ, Magalang UJ, et al. Prevalence of positional sleep apnea in patients undergoing polysomnography. Chest. 2005;128:2130-2137.
2. Morgenthaler TI, Kapen S, Lee-Chiong T, et al. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006;29:1031-1035.
3. Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children. Pediatrics. 2006;117:e61-e66.
4. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax. 2004;59:50-55.
5. Hōijer U, Ejnell H, Hedner J, et al. The effects of nasal dilation on snoring and obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992;118:281-284.
6. Petruson B. Snoring can be reduced when the nasal airflow is increased by the nasal dilator Nozovent. Arch Otolaryngol Head Neck Surg. 1990;116:462-464.
7. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1:862-865.
8. Littner M, Kushida CA, Hartse K, et al. Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000. Sleep. 2001;24:603-619.
9. Ayas NT, Patel SR, Malhotra A, et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep. 2004;27:249-253.
10. Morgenthaler TI, Gay PC, Gordon N, et al. Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep. 2007;30:468-475.
11. Patel SR, White DP, Malhotra A, Stanchina ML, et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med. 2003;163:565-571.
12. Scottish Intercollegiate Guidelines Network (SIGN). Management of obstructive sleep apnoea/hypopnoea syndrome in adults. A national clinical guideline. Edinburgh UK: SIGN, 2003 (SIGN publication no. 73).
13. Schwartz DJ, Kohler WC, Karatinos G. Symptoms of depression in individuals with obstructive sleep apnea may be amenable to treatment with continuous positive airway pressure. Chest. 2005;128:1304-1309.
14. Gay P, Weaver T, Loube D, et al, for the Positive Airway Pressure Taskforce. Evaluation of positive airway pressura treatment for sleep related breathing disorders in adults. Sleep. 2006;29:381-401.
15. Giles TL, Lasserson TJ, Smith BH, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;3:CD001106.
16. Marshall NS, Barnes M, Travier N, et al. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis. Thorax. 2006;61:430-434.
17. Egea CJ, Aizpuru F, Pinto JA, et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: A multicenter study. Sleep Med. 2007; Epub ahead of print.
18. Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, et al. Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest. 2007;132:1847-1852.
19. Findley L, Smith C, Hooper J, et al. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med. 2000;161:857-859.
20. Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007;30:711-719.
21. Liston R, Deegan PC, McCreery C, et al. Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J. 1995;8:430-435.
22. Sharkey RA, Mulloy EM, Long M, et al. The effect of continuous positive airway pressure (CPAP) on renal vascular resistance: the influence of renal denervation. Crit Care. 1999;3:33-37.
23. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993;147:887-895.
24. Sin DD, Mayers I, Man GCW, et al. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest. 2002;121:430-435.
25. Stepnowsky C Jr, Moore PJ. Nasal CPAP treatment for obstructive sleep apnea: developing a new perspective on dosing strategies and compliance. J Psychosom Res. 2003;54:599-605.
26. Pépin JL, Leger P, Veale D, et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: study of 193 patients in two French sleep centers. Chest. 1995;107:375-381.
27. Massie CA, Hart RW, Peralez K, et al. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest. 1999;116:403-408.
28. McArdle N, Devereux G, Heidamejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:1108-1114.
29. Ballard RD, Gay PC, Strollo PJ. Interventions to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. J Clin Sleep Med. 2007;3:706-712.
30. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29:375-380.
31. Littner M, Hirshkowitz M, Davila D, et al, for the Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. Sleep. 2002;25:143-147.
32. Lim J, Lasserson TJ, Fleetham J, et al. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev. 2006;1:CD004435.
33. Otsuka R, Ribeiro de Almeida F, Lowe AA, et al. The effect of oral appliance therapy an blood pressure in patients with obstructive sleep apnea. Sleep Breath. 2006;10:29-36.
34. Mehta A, Qian J, Petocz P, et al. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med. 2001;163:1457-1461.
35. Gotsopoulos H, Chen C, Qian J, et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med. 2002;166:743-748.
36. Sanders MH, Givelber RJ. Overview of obstructive sleep apnoea in adults. In: Lee-Chong, ed. Sleep disorders: A brief guide. Chichester, Uk: John Wiley & Sons; 2007:39-57.
37. Chan AS, Lee RW, Cistulli PA. Dental appliance treatment for obstructive sleep apnea. Chest. 2007;132:693-699.
38. Kushida CA, Morgenthaler TI, Littner MR, et al. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep. 2006;29:240-243.
39. Sher AE. Upper airway surgery for obstructive sleep apnea. Sleep Med Rev. 2002;6:195-212.
40. Nordgārd S, Stene BK, Skjøstad KW. Soft palate implants for the treatment of mild to moderate obstructive sleep apnea. Otolaryngol Head Neck Surg. 2006;134:565-570.
41. Stephen GA, Eichling PS, Quan SF. Treatment of sleep disordered breathing and obstructive sleep apnea. Minerva Med. 2004;95:323-336.
42. Terris DJ, Clerk AA, Norbash AM, et al. Characterization of post-operative edema following laser-assisted uvulopalatoplasty using MRI and polysomnography: implication for the outpatient treatment of obstructive sleep apnea syndrome. Laryngoscope. 1996;106:124-128.
43. Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep. 1996;19:156-177.
44. Sundaram S, Bridgman SA, Lim J, et al. Surgery for obstructive sleep apnoea. Cochrane Database Syst Rev. 2005;4:CD001004.
45. Smith PL, Haponik EF, Bleecker ER. The effects of oxygen in patients with sleep apnea. Am Rev Respir Dis. 1984;130:958-963.
46. Phillips BA, Schmitt FA, Berry DT, et al. Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest. 1991;98:325-330.
47. Veasey SC. Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential. Am J Respir Med. 2003;2:21-29.
48. Carley DW, Olopade C, Ruigt GS, et al. Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep. 2007;30:35-41.
49. Veasey SC, Guilleminault C, Strohl KP, et al. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 2006;29:1036-1044.
50. Brownell LG, West P, Sweatman P, et al. Protriptyline in obstructive sleep apnea: a double-blind trial. N Engl J Med. 1982;307:1037-1042.
51. Whyte KF, Gould GA, Airlie MA, et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep. 1988;11:463-472.
52. Smith I, Lasserson TJ, Wright J. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;2:CD003002.
53. Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep. 2005;28:464-471.
54. Dinges DF, Weaver TE. Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Med. 2003;4:393-402.
55. Kingshott RN, Vennelle M, Coleman EL, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 2001;163:918-923.
56. Schwartz JR, Hirshkowitz M, Erman MK, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest. 2003;124:2192-2199.
57. Pack AI, Black JE, Schwartz JR, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med. 2001;164:1675-1681.
58. Roth T, White D, Schmidt-Nowara W, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther. 2006;28:689-706.
59. Hirshkowitz M, Black JE, Wesnes K, et al. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med. 2007;101:616-627.
60. Feldman NT, George CF. Sleep architecture effects of sodium oxybate treatment in subjects with sleep-disordered breathing [abstract]. Chest. 2006;130(suppl):130S. http://meeting.chestjournal.org/cgi/reprint/130/4/130S-a. Accessed June 24, 2008.